MRKR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Marker Therapeutics Insider Trading History Chart

Marker Therapeutics Share Price & Price History

^$1.40

+0.30 (1.20%)

As of 05/22/2026 04:00 PM ET

Days: 30 | 90 | 365

Marker Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/23/2024	Enterprise Associates 16 New	Major Shareholder	Buy	554,250	$3.20	$1,773,600.00	1,625,678
12/23/2024	Steve Elms	Director	Buy	11,085	$3.20	$35,472.00	325,370
3/16/2023	Norman David Eansor	Director	Buy	14,285	$17.50	$249,987.50	16,713

SEC Filings (Institutional Ownership Changes) for Marker Therapeutics (NASDAQ:MRKR)

22.39% of Marker Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Marker Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2026	Renaissance Technologies LLC	175,294	$0.23M	0.0%	+41.8%	1.052%
2/18/2026	NewEdge Advisors LLC	149,000	$0.22M	0.0%	N/A	0.894%
2/18/2026	XTX Topco Ltd	58,041	$86K	0.0%	+166.6%	0.348%
2/17/2026	Osaic Holdings Inc.	94,421	$0.14M	0.0%	+16.5%	0.566%
2/12/2026	Jane Street Group LLC	40,518	$60K	0.0%	N/A	0.243%
2/12/2026	Renaissance Technologies LLC	123,650	$0.18M	0.0%	+16.4%	0.742%
2/11/2026	LPL Financial LLC	83,247	$0.12M	0.0%	+41.7%	0.499%
2/9/2026	Geode Capital Management LLC	130,344	$0.19M	0.0%	+35.3%	0.782%
1/30/2026	Boyer Financial Services Inc.	36,817	$57K	0.1%	N/A	0.221%
11/14/2025	Virtu Financial LLC	28,329	$25K	0.0%	N/A	0.219%
11/14/2025	Two Sigma Investments LP	36,540	$33K	0.0%	N/A	0.282%
8/14/2025	Jane Street Group LLC	21,800	$33K	0.0%	N/A	0.193%
5/16/2025	Alyeska Investment Group L.P.	261,777	$0.32M	0.0%	-71.4%	2.314%
2/17/2025	NEA Management Company LLC	1,625,678	$5.06M	0.3%	+51.7%	15.179%
2/17/2025	Millennium Management LLC	16,108	$50K	0.0%	N/A	0.150%
2/17/2025	Alyeska Investment Group L.P.	915,591	$2.85M	0.0%	N/A	8.549%
2/14/2025	Northern Trust Corp	54,156	$0.17M	0.0%	+66.9%	0.506%
2/14/2025	Blue Owl Capital Holdings LP	554,250	$1.72M	0.4%	N/A	5.175%
2/12/2025	Aisling Capital Management LP	325,370	$1.01M	0.4%	+3.5%	3.038%
2/11/2025	LPL Financial LLC	79,730	$0.25M	0.0%	N/A	0.744%
11/19/2024	Invst LLC	20,000	$56K	0.0%	N/A	0.224%
8/7/2024	Wedbush Securities Inc.	69,500	$0.38M	0.0%	+52.7%	0.779%
1/24/2024	International Assets Investment Management LLC	11,000	$60K	0.0%	+1,000.0%	0.124%
10/12/2023	Matrix Asset Advisors Inc. NY	15,000	$68K	0.0%	-62.5%	0.170%
7/27/2023	Virtu Financial LLC	20,472	$63K	0.0%	N/A	0.233%
7/18/2023	Matrix Asset Advisors Inc. NY	40,000	$0.12M	0.0%	+60.0%	0.455%
5/17/2023	Long Focus Capital Management LLC	146,100	$0.10M	0.0%	-90.0%	1.660%
5/12/2023	Long Focus Capital Management LLC	68,400	$49K	0.0%	-95.3%	0.777%
5/9/2023	Aisling Capital Management LP	314,286	$0.22M	0.1%	-90.0%	3.571%
5/9/2023	AR Asset Management Inc.	40,700	$29K	0.0%	N/A	0.463%
1/19/2023	Matrix Asset Advisors Inc. NY	250,000	$68K	0.0%	-37.5%	0.299%
11/15/2022	Long Focus Capital Management LLC	1,461,000	$0.54M	0.1%	-40.0%	1.748%
10/25/2022	Raymond James & Associates	94,000	$35K	0.0%	N/A	0.112%
10/24/2022	Matrix Asset Advisors Inc. NY	400,000	$0.15M	0.0%	+60.0%	0.478%
7/15/2022	Matrix Asset Advisors Inc. NY	250,000	$83K	0.0%	+66.7%	0.299%
5/10/2022	AR Asset Management Inc.	279,000	$0.12M	0.0%	+290.2%	0.336%
4/19/2022	Wedbush Securities Inc.	90,068	$40K	0.0%	+44.0%	0.108%
2/15/2022	Kennedy Capital Management Inc.	590,118	$0.56M	0.0%	-3.5%	0.710%
2/14/2022	Long Focus Capital Management LLC	1,233,257	$1.17M	0.2%	N/A	1.484%
2/10/2022	Acadian Asset Management LLC	39,507	$37K	0.0%	N/A	0.048%

Data available starting January 2016

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Today's Range

Now: $1.40

$1.40

$1.47

50 Day Range

MA: $1.44

$1.24

$1.75

52 Week Range

Now: $1.40

$0.81

$4.07

Volume

63,234 shs

Average Volume

64,565 shs

Market Capitalization

$23.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Marker Therapeutics?: Marker Therapeutics' top insider shareholders include:
John Robert Wilson (Director)
Juan Vera (Insider)
Enterprise Associates 16 New (Major Shareholder)
Peter L Hoang (CEO)
Steve Elms (Director)
Norman David Eansor (Director)
Frederick Gerald Wasserman (Director)
Paul Edward Walker (Major Shareholder)
Peter L Hoang (Insider)
Learn More about top insider investors at Marker Therapeutics.
Who are the major institutional investors of Marker Therapeutics?: Marker Therapeutics' top institutional investors include:
Renaissance Technologies LLC — 1.05%
Learn More about top institutional investors of Marker Therapeutics stock.
Which major investors are buying Marker Therapeutics stock?: Within the last quarter, MRKR stock was acquired by institutional investors including:
Renaissance Technologies LLC
In the last year, these company insiders have bought Marker Therapeutics stock:
Enterprise Associates 16 New (Major Shareholder)
Steve Elms (Director)
Learn More investors buying Marker Therapeutics stock.